NEWS FROM THE ECF

Principal Investigators’ Signatures

Aligning the existing eCF best practices document with the most recent regulatory expectations

  • 4 March 2021
  • Author: Kenichi Nakano
  • Number of views: 9168
  • 0 Comments
Principal Investigators’ Signatures

The current regulatory expectation is the investigators review and sign-off the data entered into eCRFs and other data collection tools at critical timings (including prior to interim analysis and the final analysis) in a timely manner.  eClinical Forum issued a best practices document titled “Investigator’s signature on electronic Case Report Forms (eCRFs) in 2017.  This team will review and align this existing document with most recent regulatory expectations on signatures collection on eCRF and eCOA data.  A draft is anticipated in October 2021 and the release to the members by end of December 2021.

Print
Tags:
Rate this article:
5.0
«November 2026»
MonTueWedThuFriSatSun
2627282930311
2345678
910

eCF Webinar November: FDA warning letters for audit trail analytics

FDA warning letters tell us what went wrong, but what could your audit trail analytics program have caught earlier? Join our upcoming webinar for a practical, in-depth look at an FDA warning letter and learn how to identify missed signals, uncover blind spots, and strengthen your audit trail review program.

Read more
1112131415
16171819202122
23242526272829
30123456